Most published studies supporting the use of procalcitonin over conventional inflammatory markers (eg C-reactive protein, CRP) have compared procalcitonin in patients with bacterial infection and those with non-infective diseases or other non-bacterial infections [1]. This evidence concerns the gene CRP and bacterial infectious disease.